Found: 3
Select item for more details and to access through your institution.
Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics - results from single oral dose studies in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 5, p. 1240, doi. 10.1111/j.1365-2125.2012.04471.x
- By:
- Publication type:
- Article
Barriers for Nurses to Safe Medication Management in Nursing Homes.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
The year in cardiology 2014: peripheral circulation.
- Published in:
- European Heart Journal, 2015, v. 36, n. 10, p. 591
- By:
- Publication type:
- Article